EDESA BIOTECH INC (EDSA) Stock Analyst Earnings Estimates
NASDAQ:EDSA - Nasdaq - CA27966L3065 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 210K -8.70% | 410K 95.24% | 330K -19.51% | -100.00% | |||||||
| EBITDA YoY % growth | -4.89M 2.98% | -2.83M 42.13% | -6.34M -124.03% | -12.24M -271.61% | N/A 22.54% | N/A 50.47% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -5.08M 2.68% | -2.83M 44.29% | -6.4M -126.15% | -24.897M -270.00% | -22.338M 22.42% | -9.213M 49.79% | -8.568M 7.10% | -8.262M 3.57% | -7.65M 7.41% | -8.16M -6.67% | |
| Operating Margin | -2,419.05% | -690.24% | -1,939.39% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -7.31 63.92% | -10.25 -332.35% | -4.62 58.50% | -2.65 36.72% | -2.10 -8.61% | -1.37 34.79% | -0.98 28.36% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.32 41.44% | -0.39 33.17% | -0.51 1.92% | -0.57 -96.97% |
| Revenue Q2Q % growth | ||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -1.224M 34.10% | -1.428M 35.69% | -1.836M 4.99% | -2.04M -103.11% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -0.29 51.67% | -0.55 | 0.26 | 47.35% |
| Q3 2024 Q2Q % growth | -0.52 25.71% | -0.59 | 0.07 | 12.10% |
| Q2 2024 Q2Q % growth | -0.58 30.95% | -0.71 | 0.13 | 17.99% |
| Q1 2024 Q2Q % growth | -0.54 40.66% | -1.23 | 0.69 | 56.25% |
| Q4 2023 Q2Q % growth | -0.60 -328.57% | -0.72 | 0.12 | 16.76% |
| Q3 2023 Q2Q % growth | -0.70 72.97% | -1.24 | 0.54 | 43.44% |
| Q2 2023 Q2Q % growth | -0.84 63.64% | -1.24 | 0.40 | 32.13% |
| Q1 2023 Q2Q % growth | -0.91 60.61% | -1.36 | 0.45 | 32.92% |
| Q4 2022 Q2Q % growth | -0.14 48.15% | -2.82 | 2.68 | 95.04% |
| Q3 2022 Q2Q % growth | -2.59 -619.44% | -3.07 | 0.48 | 15.64% |
| Q2 2022 Q2Q % growth | -2.31 -185.19% | -2.62 | 0.31 | 11.77% |
| Q1 2022 Q2Q % growth | -2.31 -788.46% | -2.86 | 0.55 | 19.12% |
| Q4 2021 Q2Q % growth | -0.27 -22.73% | -0.37 | 0.10 | 27.81% |
| Q3 2021 Q2Q % growth | -0.36 -80.00% | -0.33 | -0.03 | -10.29% |
| Q2 2021 Q2Q % growth | -0.81 -376.47% | -0.30 | -0.51 | -169.19% |
| Q1 2021 Q2Q % growth | -0.26 | -0.19 | -0.07 | -34.16% |
| Q4 2020 Q2Q % growth | -0.22 | -0.21 | -0.01 | -5.21% |
| Q3 2020 Q2Q % growth | -0.20 | -0.21 | 0.01 | 4.35% |
| Q2 2020 Q2Q % growth | -0.17 | -0.19 | 0.02 | 12.28% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2021 Q2Q % growth | -100.00% | % | ||
| Q2 2021 Q2Q % growth | -100.00% | % | ||
| Q1 2021 Q2Q % growth | -100.00% | 102K | -102K | -100.00% |
| Q4 2020 Q2Q % growth | -100.00% | 51K | -51K | -100.00% |
| Q3 2020 Q2Q % growth | 110K | 51K | 59K | 115.69% |
| Q2 2020 Q2Q % growth | 110K -8.33% | 51K | 59K | 115.69% |
| Q1 2020 Q2Q % growth | 110K 120.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | -20.65% |
| Revenue | N/A | N/A | N/A | N/A |